DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Circulating tumor cell
Circulating tumor cell
Circulating Tumor Cell As a Diagnostic Marker in Primary Lung Cancer
797 Circulating Tumor DNA and Circulating Tumor Cells for Cancer
Circulating Tumor Cells
Liquid Biopsy Testing
Discrete Microfluidics for the Isolation of Circulating Tumor Cell
Evaluation of Sensitivity and Specificity of Canpatroltm Technology For
A Review on Microdevices for Isolating Circulating Tumor Cells
Technical Validation of a New Microfluidic Device for Enrichment Of
Circulating Tumour Cells from Patients with Colorectal Cancer Have
Circulating Cancer Stem Cell Markers in Breast Carcinomas: a Systematic Review Protocol Maryam Mansoori1, Zahra Madjd2*, Leila Janani3* and Arezoo Rasti4
Circulating Tumor Cell Count
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but Not in Healthy Subjects Or Patients with Nonmalignant Diseases
Cytopathological Heterogeneity of Circulating Tumor Cells in Non-Metastatic Esophageal Adenocarcinoma JASMINA KUVENDJISKA 1,2 , MARTHA B
Circulating Tumor Cells Improves Diagnosis of Small Pulmonary Nodules
The Viable Circulating Tumor Cells with Cancer Stem Cells Feature, Where Is the Way Out? Y
Circulating Tumor Cells: from the Laboratory to the Cancer Clinic
Sensitive and Specific Detection of Circulating Tumor Cells Promotes Precision Medicine for Cancer
Final Comments and Response for Circulating Tumor Cell Marker
Top View
Circulating Tumor Cells (Ctcs): a Unique Model of Cancer Metastases and Non-Invasive Biomarkers of Therapeutic Response
Apoptotic Circulating Tumor Cells in Early and Metastatic Breast Cancer Patients
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA As Liquid Biopsy
Clinical Relevance of Serum HER2 and Circulating Tumor Cell
Pathological Response and Circulating Tumor Cell Count
The Impact of HER2 Phenotype of Circulating Tumor Cells in Metastatic
Cellsearch Circulating Tumor Cell Count for Breast Cancer Prognosis
Circulating Tumor Cells As a Biomarker for Precise Management of Lung Cancer
Circulating Tumor Cell Heterogeneity in Neuroendocrine Prostate Cancer by Single Cell Copy Number Analysis
Comparison of Circulating Tumor Cell (CTC)
Number: K062013 B. Purpose for Submission
Baseline Cd44v6-Positive Circulating Tumor Cells to Predict First- Line Treatment Failure in Patients with Metastatic Colorectal Cancer
Legacy Biomarker Qualification Project Status Update Menarini
HER2 Status of Circulating Tumor Cells in Patients with Metastatic Breast
High Throughput Circulating Tumor Cell Isolation Using
510(K) SUMMARY
Evaluation of Sensitivity and Specificity of Canpatrol™ Technology For
Circulating Tumor Cell Status Monitors the Treatment Responses In
Cell-Surface Vimentin Transformed EMT Ctcs and Cscs in Metastatic Castration-Resistant Prostate Cancer Application Note
Novel Circulating Tumor Cell Assay for Detection of Colorectal
Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
Actionability of HER2-Amplified Circulating Tumor Cells in HER2
The Role of Circulating Tumor Cells in Chemoresistant Metastatic Breast Cancer
Classification of Large Circulating Tumor Cells Isolated with Ultra- High Throughput Microfluidic Vortex Technology
Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)
Cellsearch® Technology Applied to the Detection and Quantification Of
Position of Circulating Tumor Cells in the Clinical Routine in Prostate Cancer and Breast Cancer Patients
Detection of Circulating Tumor Cells: Clinical Relevance of a Novel Metastatic Tumor Marker (Review)
Circulating Tumor Cells in Solid Tumor in Metastatic and Localized Stages
Circulating Tumor Cell Subtypes and T-Cell Populations As Prognostic
The Detection of Stem-Like Circulating Tumor Cells Could Increase the Clinical Applicability of Liquid Biopsy in Ovarian Cancer
Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities
Emerging Role of Circulating Tumor Cells in Gastric Cancer
Detection of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer Using a Size-Based Platform
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability As a Distinctive Feature of Aggressive Prostate Cancer Paymaneh D
Clinical Applications of Circulating Tumor Cells in Pharmacotherapy: Challenges and Perspectives
Circulating Tumor Cells Develop Resistance to TRAIL-Induced Apoptosis Through Autophagic Removal of Death Receptor 5: Evidence from an in Vitro Model
Functional Profiling of Circulating Tumor Cells with an Integrated Vortex Capture and Single-Cell Protease Activity Assay
A Conduit to Metastasis: Circulating Tumor Cell Biology
A Review of Circulating Tumour Cell Enrichment Technologies
Detection of Circulating Tumor Cells and Cell Free DNA
Efficacy of Adding Trastuzumab to Standard
Liquid Biopsy)
In Vivo Isolation of Circulating Tumor Cells in Patients with Different Stages of Prostate Cancer
Relationship Between Circulating Tumor Cells and Peripheral T-Cells in Patients with Primary Breast Cancer
Prognostic Impact of Circulating Tumor Cell Apoptosis and Clusters in Serial
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature
Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal
K071729 B. Purpose for Submission
Clinical Significance of Circulating Tumor Cell Related Markers